Revenue
$551.68M
Fiscal year ended 2026-06-30Operating income
$39.13M
Fiscal year ended 2026-06-30Free cash flow
$61.64M
Fiscal year ended 2026-06-30ICU MEDICAL INC/DE (ICUI) reported revenue of $551.68M and net income of $19.09M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from ICU MEDICAL INC/DE’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $551.68M | $530.22M | $540.70M | $536.99M | $548.87M | $604.70M | $629.80M | $589.13M | $596.46M | $566.66M |
| Cost of revenue | $316.63M | $324.00M | Unavailable | $336.11M | $340.80M | $394.59M | Unavailable | $384.28M | $389.03M | $381.41M |
| Gross profit | $235.05M | $206.23M | $202.98M | $200.88M | $208.06M | $210.11M | $227.26M | $204.85M | $207.43M | $185.24M |
| Operating income | $39.13M | $13.58M | $5.64M | $13.72M | $10.59M | $12.89M | $37.69M | $8.24M | $7.69M | -$10.66M |
| Net income | $19.09M | $30.13M | Unavailable | -$3.40M | $35.34M | -$15.48M | Unavailable | -$32.98M | -$21.41M | -$39.47M |
| Research & development | $22.70M | $21.28M | $21.09M | $21.25M | $21.87M | $23.29M | $22.36M | $21.03M | $23.39M | $21.84M |
| Weighted-average diluted shares | shares 25.04M | shares 25.18M | Unavailable | shares 24.69M | shares 24.71M | shares 24.54M | Unavailable | shares 24.44M | shares 24.39M | shares 24.22M |
| Pretax income | $23.14M | -$3.98M | Unavailable | -$2.51M | $33.68M | -$10.91M | Unavailable | -$17.93M | -$19.53M | -$36.77M |
| Income tax expense | $7.07M | -$34.71M | -$2.65M | -$658.00K | $1.18M | $4.57M | $32.04M | $15.06M | $1.87M | $2.70M |
| Diluted EPS | $0.76 | $1.20 | Unavailable | $-0.14 | $1.43 | $-0.63 | Unavailable | $-1.35 | $-0.88 | $-1.63 |
| Selling, general & administrative | $151.92M | $154.57M | $155.81M | $152.77M | $159.39M | $157.23M | $158.85M | $162.71M | $159.55M | $157.66M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | $4.18B | $4.20B | $4.31B | $4.29B | $4.29B |
| Current assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | $1.42B | $1.44B | $1.26B | $1.24B | $1.19B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $498.36M | $517.90M | $498.86M | $492.90M | $482.78M | $549.02M | $556.18M | $549.56M | $511.91M | $455.36M |
| Total equity incl. NCI | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | $1.99B | $1.97B | $2.05B | $2.04B | $2.07B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $607.42M | $605.59M | $615.86M | $622.44M | $616.47M | $590.33M | $584.68M | $692.04M | $682.87M | $693.01M |
| Accounts receivable | $183.53M | $201.08M | $180.52M | $191.54M | $179.50M | $170.93M | $182.83M | $173.98M | $151.76M | $145.19M |
| Goodwill | $1.48B | $1.49B | $1.50B | $1.50B | $1.50B | $1.46B | $1.43B | $1.48B | $1.45B | $1.46B |
| Long-term debt | $1.21B | $1.26B | $1.27B | $1.31B | $1.34B | $1.49B | $1.53B | $1.54B | $1.55B | $1.57B |
| Accounts payable | $149.16M | $173.98M | $154.37M | $171.75M | $168.82M | $180.41M | $148.02M | $168.56M | $155.52M | $152.48M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $80.15M | $38.91M | $60.60M | $56.71M | $11.21M | $51.33M | $40.19M | $36.10M | $81.95M | $45.79M |
| Capital expenditures | $18.51M | $11.30M | $24.65M | $29.08M | $19.70M | $14.62M | $24.08M | $19.91M | $19.47M | $15.92M |
| Investing cash flow | -$20.14M | -$11.21M | -$18.39M | -$30.03M | $187.46M | -$16.81M | -$26.55M | -$22.86M | -$21.69M | -$17.86M |
| Financing cash flow | -$50.24M | -$44.12M | -$34.48M | -$25.69M | -$195.02M | -$56.34M | -$8.19M | -$10.38M | -$10.38M | -$26.84M |
| Net change in cash | $9.97M | -$19.63M | $8.23M | -$293.00K | $10.32M | -$18.86M | -$3.95M | $9.86M | $51.22M | -$2.80M |
| Stock-based compensation | $11.87M | $14.01M | $13.88M | $15.24M | $14.46M | $12.18M | $12.52M | $11.77M | $11.00M | $11.60M |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $49.61M | $50.03M | $50.83M | $50.80M | $49.66M | $49.44M | $52.99M | $55.68M | $55.32M | $55.53M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $61.64M | $27.61M | $35.95M | $27.63M | -$8.48M | $36.71M | $16.11M | $16.19M | $62.49M | $29.88M |
| Gross margin | 42.6% | 38.9% | 37.5% | 37.4% | 37.9% | 34.7% | 36.1% | 34.8% | 34.8% | 32.7% |
| Operating margin | 7.1% | 2.6% | 1.0% | 2.6% | 1.9% | 2.1% | 6.0% | 1.4% | 1.3% | -1.9% |
| FCF margin | 11.2% | 5.2% | 6.6% | 5.1% | -1.5% | 6.1% | 2.6% | 2.7% | 10.5% | 5.3% |
| SBC / revenue | 2.2% | 2.6% | 2.6% | 2.8% | 2.6% | 2.0% | 2.0% | 2.0% | 1.8% | 2.0% |
| Current ratio | 2.43x | 2.34x | 2.39x | 2.45x | 2.44x | 2.59x | 2.59x | 2.29x | 2.41x | 2.61x |
| Revenue YoY growth | 0.5% | -12.3% | -14.1% | -8.9% | -8.0% | 6.7% | 7.1% | 6.5% | 8.6% | -0.4% |
| Net margin | 3.5% | Unavailable | Unavailable | -0.6% | 6.4% | Unavailable | Unavailable | -5.6% | Unavailable | Unavailable |
| R&D / revenue | 4.1% | 4.0% | 3.9% | 4.0% | 4.0% | 3.9% | 3.5% | 3.6% | 3.9% | 3.9% |
| CapEx / revenue | 3.4% | 2.1% | 4.6% | 5.4% | 3.6% | 2.4% | 3.8% | 3.4% | 3.3% | 2.8% |
| Long-term debt / equity | 0.56x | Unavailable | 0.60x | 0.62x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 30.5% | Unavailable | Unavailable | Unavailable | 3.5% | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ICUI in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-07View SEC filing
10-K · Filed 2026-02-19View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.